Literature DB >> 22575403

Vascular dementia.

Amos D Korczyn1, Veronika Vakhapova, Lea T Grinberg.   

Abstract

The epidemic growth of dementia causes great concern for the society. It is customary to consider Alzheimer's disease (AD) as the most common cause of dementia, followed by vascular dementia (VaD). This dichotomous view of a neurodegenerative disease as opposed to brain damage caused by extrinsic factors led to separate lines of research in these two entities. Indeed, accumulated data suggest that the two disorders have additive effects and probably interact; however it is still unknown to what degree. Furthermore, epidemiological studies have shown "vascular" risk factors to be associated with AD. Therefore, a clear distinction between AD and VaD cannot be made in most cases, and is furthermore unhelpful. In the absence of efficacious treatment for the neurodegenerative process, special attention must be given to the vascular component, even in patients with presumed mixed pathology. Symptomatic treatment of VaD and AD is similar, although the former is less effective. For prevention of dementia it is important to treat all factors aggressively, even in stroke survivors who do not show evidence of cognitive decline. In this review, we will give a clinical and pathological picture of the processes leading to VaD and discuss its interaction with AD.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22575403      PMCID: PMC3435447          DOI: 10.1016/j.jns.2012.03.027

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  123 in total

Review 1.  Epidemiology of vascular dementia.

Authors:  D Leys; F Pasquier; L Parnetti
Journal:  Haemostasis       Date:  1998 May-Aug

2.  Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up.

Authors:  R Moretti; P Torre; R M Antonello; G Cazzato
Journal:  Eur J Neurol       Date:  2001-07       Impact factor: 6.089

3.  Natural history of dementia associated with lacunar infarctions.

Authors:  Judith Aharon-Peretz; Ella Daskovski; Tatiana Mashiach; Rachel Tomer
Journal:  J Neurol Sci       Date:  2002-11-15       Impact factor: 3.181

4.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.

Authors:  Françoise Forette; Marie-Laure Seux; Jan A Staessen; Lutgarde Thijs; Marija-Ruta Babarskiene; Speranta Babeanu; Alfredo Bossini; Robert Fagard; Blas Gil-Extremera; Tovio Laks; Zhanna Kobalava; Cinzia Sarti; Jaakko Tuomilehto; Hannu Vanhanen; John Webster; Yair Yodfat; Willem H Birkenhäger
Journal:  Arch Intern Med       Date:  2002-10-14

5.  Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study.

Authors:  A Labate; A Gambardella; U Aguglia; F Condino; P Ventura; P Lanza; A Quattrone
Journal:  Neurology       Date:  2010-01-20       Impact factor: 9.910

6.  Association of diabetes, homocysteine, and HDL with cognition and disability after stroke.

Authors:  George C Newman; Heejung Bang; Syed I Hussain; James F Toole
Journal:  Neurology       Date:  2007-11-27       Impact factor: 9.910

Review 7.  Hippocampal sclerosis dementia: a reappraisal.

Authors:  Alphonse Probst; Kirsten I Taylor; Markus Tolnay
Journal:  Acta Neuropathol       Date:  2007-07-17       Impact factor: 17.088

8.  ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia.

Authors:  J Chapman; N Wang; T A Treves; A D Korczyn; N M Bornstein
Journal:  Stroke       Date:  1998-07       Impact factor: 7.914

9.  Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study.

Authors:  Christelle Raffaitin; Henri Gin; Jean-Philippe Empana; Catherine Helmer; Claudine Berr; Christophe Tzourio; Florence Portet; Jean-François Dartigues; Annick Alpérovitch; Pascale Barberger-Gateau
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 19.112

10.  Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study.

Authors:  Weili Xu; Chengxuan Qiu; Margaret Gatz; Nancy L Pedersen; Boo Johansson; Laura Fratiglioni
Journal:  Diabetes       Date:  2008-10-24       Impact factor: 9.461

View more
  42 in total

1.  [Mild dementia and driving ability. Part 1: Fundamentals].

Authors:  D K Wolter
Journal:  Z Gerontol Geriatr       Date:  2014-04       Impact factor: 1.281

2.  Common Aging Signature in the Peripheral Blood of Vascular Dementia and Alzheimer's Disease.

Authors:  Hongbo Luo; Guangchun Han; Jiajia Wang; Fan Zeng; Yuanming Li; Shaoju Shao; Fuhai Song; Zhouxian Bai; Xing Peng; Yan-Jiang Wang; Xiangqun Shi; Hongxing Lei
Journal:  Mol Neurobiol       Date:  2015-06-23       Impact factor: 5.590

3.  (2R,3S)-Pinobanksin-3-cinnamate improves cognition and reduces oxidative stress in rats with vascular dementia.

Authors:  Hong Liu; Min Zhao; Shen Yang; Dian-Rong Gong; De-Zhe Chen; De-Yong Du
Journal:  J Nat Med       Date:  2015-03-26       Impact factor: 2.343

4.  Discrimination of stroke-related mild cognitive impairment and vascular dementia using EEG signal analysis.

Authors:  Noor Kamal Al-Qazzaz; Sawal Hamid Bin Mohd Ali; Siti Anom Ahmad; Mohd Shabiul Islam; Javier Escudero
Journal:  Med Biol Eng Comput       Date:  2017-11-08       Impact factor: 2.602

5.  Assessment of free and cued recall in Alzheimer's disease and vascular and frontotemporal dementia with 24-item Grober and Buschke test.

Authors:  Milena Cerciello; Valeria Isella; Alice Proserpi; Costanza Papagno
Journal:  Neurol Sci       Date:  2016-09-26       Impact factor: 3.307

6.  Heart failure and risk of dementia: a Danish nationwide population-based cohort study.

Authors:  Kasper Adelborg; Erzsébet Horváth-Puhó; Anne Ording; Lars Pedersen; Henrik Toft Sørensen; Victor W Henderson
Journal:  Eur J Heart Fail       Date:  2016-09-09       Impact factor: 15.534

7.  Protective effect of carnosine after chronic cerebral hypoperfusion possibly through suppressing astrocyte activation.

Authors:  Jing Ma; Jihui Chen; Shuhong Bo; Xiaotong Lu; Jian Zhang
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

8.  Is Alzheimer's disease a homogeneous disease entity?

Authors:  Amos D Korczyn
Journal:  J Neural Transm (Vienna)       Date:  2013-08-11       Impact factor: 3.575

Review 9.  The common dementias: a pictorial review.

Authors:  Pervinder Bhogal; Colin Mahoney; Sophie Graeme-Baker; Amit Roy; Sachit Shah; Francesco Fraioli; Peter Cowley; Hans Rolf Jäger
Journal:  Eur Radiol       Date:  2013-10-01       Impact factor: 5.315

10.  CZ-7, a new derivative of Claulansine F, ameliorates 2VO-induced vascular dementia in rats through a Nrf2-mediated antioxidant responses.

Authors:  Dan-Dan Liu; Xia Yuan; Shi-Feng Chu; Chen Chen; Qian Ren; Piao Luo; Mei-Yu Lin; Sha-Sha Wang; Tian-Bi Zhu; Qi-di Ai; Ying-da Zang; Dong-Ming Zhang; Xin He; Zhi-Hua Huang; Hong-Shuo Sun; Zhong-Ping Feng; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2018-10-31       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.